Among them, SNHG12 has been reported in highly expressed quantities in gastric cancer, triple-negative breast cancer and colon cancer with direct proportion to the growth and development of tumor tissue and cells. This evidence concerns the gene SNHG12 and triple-negative breast carcinoma.